Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15495093rdf:typepubmed:Citationlld:pubmed
pubmed-article:15495093lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:15495093lifeskim:mentionsumls-concept:C0019080lld:lifeskim
pubmed-article:15495093lifeskim:mentionsumls-concept:C0086818lld:lifeskim
pubmed-article:15495093lifeskim:mentionsumls-concept:C1504389lld:lifeskim
pubmed-article:15495093lifeskim:mentionsumls-concept:C0677582lld:lifeskim
pubmed-article:15495093lifeskim:mentionsumls-concept:C0445202lld:lifeskim
pubmed-article:15495093lifeskim:mentionsumls-concept:C0355642lld:lifeskim
pubmed-article:15495093pubmed:issue4lld:pubmed
pubmed-article:15495093pubmed:dateCreated2004-10-20lld:pubmed
pubmed-article:15495093pubmed:abstractTextPlatelet transfusions are used in modern clinical practice to prevent and treat bleeding in thrombocytopenic patients with bone marrow failure. Although considerable advances have been made in platelet transfusion therapy in the last 30 years, some areas continue to provoke debate, especially the use of prophylactic platelet transfusions for the prevention of thrombocytopenic bleeding.lld:pubmed
pubmed-article:15495093pubmed:languageenglld:pubmed
pubmed-article:15495093pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15495093pubmed:citationSubsetIMlld:pubmed
pubmed-article:15495093pubmed:statusMEDLINElld:pubmed
pubmed-article:15495093pubmed:issn1469-493Xlld:pubmed
pubmed-article:15495093pubmed:authorpubmed-author:MurphyM FMFlld:pubmed
pubmed-article:15495093pubmed:authorpubmed-author:RebullaPPlld:pubmed
pubmed-article:15495093pubmed:authorpubmed-author:HydoMMlld:pubmed
pubmed-article:15495093pubmed:authorpubmed-author:StanworthS...lld:pubmed
pubmed-article:15495093pubmed:authorpubmed-author:HeddleNNlld:pubmed
pubmed-article:15495093pubmed:authorpubmed-author:BrunskillSSlld:pubmed
pubmed-article:15495093pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15495093pubmed:ownerNLMlld:pubmed
pubmed-article:15495093pubmed:authorsCompleteYlld:pubmed
pubmed-article:15495093pubmed:paginationCD004269lld:pubmed
pubmed-article:15495093pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15495093pubmed:meshHeadingpubmed-meshheading:15495093...lld:pubmed
pubmed-article:15495093pubmed:meshHeadingpubmed-meshheading:15495093...lld:pubmed
pubmed-article:15495093pubmed:meshHeadingpubmed-meshheading:15495093...lld:pubmed
pubmed-article:15495093pubmed:meshHeadingpubmed-meshheading:15495093...lld:pubmed
pubmed-article:15495093pubmed:meshHeadingpubmed-meshheading:15495093...lld:pubmed
pubmed-article:15495093pubmed:meshHeadingpubmed-meshheading:15495093...lld:pubmed
pubmed-article:15495093pubmed:year2004lld:pubmed
pubmed-article:15495093pubmed:articleTitleProphylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.lld:pubmed
pubmed-article:15495093pubmed:affiliationNational Blood Service, UK National Health Service, Level 2 , John Ratcliffe Hospital, Heddington, Oxford, UK, OX3 9DU. simon.stanworth@nbs.nhs.uklld:pubmed
pubmed-article:15495093pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15495093pubmed:publicationTypeReviewlld:pubmed
pubmed-article:15495093pubmed:publicationTypeMeta-Analysislld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15495093lld:pubmed